Compare URGN & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URGN | SHO |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2016 | 2004 |
| Metric | URGN | SHO |
|---|---|---|
| Price | $43.39 | $10.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $29.29 | $9.79 |
| AVG Volume (30 Days) | 985.0K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $1,128,000.00 | ★ $1,115,167,000.00 |
| Revenue This Year | $129.09 | $3.95 |
| Revenue Next Year | $70.96 | $2.30 |
| P/E Ratio | ★ N/A | $50.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.86 | $8.69 |
| 52 Week High | $50.81 | $12.07 |
| Indicator | URGN | SHO |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 40.00 |
| Support Level | $18.25 | $8.84 |
| Resistance Level | $43.93 | $12.01 |
| Average True Range (ATR) | 1.82 | 0.23 |
| MACD | -0.90 | 0.01 |
| Stochastic Oscillator | 14.81 | 55.04 |
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.